• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Aspirin in patients with glucose-6-phosphate dehydrogenase deficiency: a true clinical issue?葡萄糖-6-磷酸脱氢酶缺乏症患者使用阿司匹林：一个真正的临床问题？
Eur Heart J Cardiovasc Pharmacother. 2025 Mar 13;11(2):112-113. doi: 10.1093/ehjcvp/pvae101.
2
Safety and efficacy of low-dose aspirin in ischemic stroke patients with different G6PD conditions.不同 G6PD 状态的缺血性脑卒中患者中低剂量阿司匹林的安全性和有效性。
Int J Stroke. 2021 Jun;16(4):411-419. doi: 10.1177/1747493020950903. Epub 2020 Sep 2.
3
Aspirin Therapy in Cardiovascular Disease with Glucose-6-Phosphate Dehydrogenase Deficiency, Safe or Not?葡萄糖-6-磷酸脱氢酶缺乏症患者的心血管疾病中应用阿司匹林治疗：安全吗？
Am J Cardiovasc Drugs. 2021 Jul;21(4):377-382. doi: 10.1007/s40256-020-00460-8. Epub 2020 Dec 14.
4
Antiplatelet and invasive treatment in patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency and acute coronary syndrome. The safety of aspirin.葡萄糖-6-磷酸脱氢酶（G6PD）缺乏症与急性冠状动脉综合征患者的抗血小板和侵入性治疗。阿司匹林的安全性。
J Clin Pharm Ther. 2015 Jun;40(3):349-52. doi: 10.1111/jcpt.12262. Epub 2015 Mar 25.
5
Long-term, low-dose aspirin is safe in glucose-6-phosphate dehydrogenase deficiency.长期低剂量阿司匹林对于葡萄糖-6-磷酸脱氢酶缺乏症患者是安全的。
DICP. 1991 Oct;25(10):1074-5. doi: 10.1177/106002809102501010.
6
Aspirin adherence in subjects with glucose-6-phosphate-dehydrogenase deficiency having an acute coronary syndrome.葡萄糖-6-磷酸脱氢酶缺乏的急性冠状动脉综合征患者的阿司匹林依从性
Eur Heart J Cardiovasc Pharmacother. 2021 May 23;7(3):e41-w44. doi: 10.1093/ehjcvp/pvaa060.
7
Aspirin safety in glucose-6-phosphate dehydrogenase deficiency patients with acute coronary syndrome undergoing percutaneous coronary intervention.葡萄糖-6-磷酸脱氢酶缺乏的急性冠状动脉综合征患者在接受经皮冠状动脉介入治疗时阿司匹林的安全性。
BMJ Case Rep. 2017 Oct 9;2017:bcr-2017-220483. doi: 10.1136/bcr-2017-220483.
8
Late-onset aspirin-related hemolysis and subsequent subdural hemorrhage in patient with glucose-6-phosphate dehydrogenase deficiency.葡萄糖-6-磷酸脱氢酶缺乏症患者迟发性阿司匹林相关溶血及随后的硬膜下出血
Clin Case Rep. 2024 Jan 30;12(2):e8450. doi: 10.1002/ccr3.8450. eCollection 2024 Feb.
9
Dual Antiplatelet Therapy in Patients with Glucose-6-Phosphate Dehydrogenase Deficiency undergoing PCI with Drug-Eluting Stents.葡萄糖-6-磷酸脱氢酶缺乏症患者接受药物洗脱支架PCI时的双联抗血小板治疗
J Atheroscler Thromb. 2015;22(5):535-41. doi: 10.5551/jat.29371. Epub 2015 Apr 3.
10
Aspirin and glucose-6-phosphate dehydrogenase deficiency.阿司匹林与葡萄糖-6-磷酸脱氢酶缺乏症
Br Med J (Clin Res Ed). 1981 Oct 31;283(6300):1189. doi: 10.1136/bmj.283.6300.1189-c.

本文引用的文献

1
P2Y12 inhibitor monotherapy after short DAPT in acute coronary syndrome: a systematic review and meta-analysis.急性冠状动脉综合征中短期 DAPT 后 P2Y12 抑制剂单药治疗：系统评价和荟萃分析。
Eur Heart J Cardiovasc Pharmacother. 2024 Nov 6;10(7):588-598. doi: 10.1093/ehjcvp/pvae057.
2
Late-onset aspirin-related hemolysis and subsequent subdural hemorrhage in patient with glucose-6-phosphate dehydrogenase deficiency.葡萄糖-6-磷酸脱氢酶缺乏症患者迟发性阿司匹林相关溶血及随后的硬膜下出血
Clin Case Rep. 2024 Jan 30;12(2):e8450. doi: 10.1002/ccr3.8450. eCollection 2024 Feb.
3
Impact of ethnicity on antiplatelet treatment regimens for bleeding reduction in acute coronary syndromes: a systematic review and pre-specified subgroup meta-analysis.族群对减少急性冠脉综合征出血的抗血小板治疗方案的影响：系统评价和预先指定的亚组荟萃分析。
Eur Heart J Cardiovasc Pharmacother. 2024 Feb 23;10(2):158-169. doi: 10.1093/ehjcvp/pvad085.
4
Antiplatelet therapy after percutaneous coronary intervention.经皮冠状动脉介入治疗后的抗血小板治疗。
EuroIntervention. 2022 Apr 1;17(17):e1371-e1396. doi: 10.4244/EIJ-D-21-00904.
5
Association between aspirin-induced hemoglobin decline and outcome after acute ischemic stroke in G6PD-deficient patients.葡萄糖-6-磷酸脱氢酶（G6PD）缺乏症患者急性缺血性脑卒中后阿司匹林诱导的血红蛋白下降与结局的关系。
CNS Neurosci Ther. 2021 Oct;27(10):1206-1213. doi: 10.1111/cns.13711. Epub 2021 Aug 8.
6
Aspirin Therapy in Cardiovascular Disease with Glucose-6-Phosphate Dehydrogenase Deficiency, Safe or Not?葡萄糖-6-磷酸脱氢酶缺乏症患者的心血管疾病中应用阿司匹林治疗：安全吗？
Am J Cardiovasc Drugs. 2021 Jul;21(4):377-382. doi: 10.1007/s40256-020-00460-8. Epub 2020 Dec 14.
7
Safety and efficacy of low-dose aspirin in ischemic stroke patients with different G6PD conditions.不同 G6PD 状态的缺血性脑卒中患者中低剂量阿司匹林的安全性和有效性。
Int J Stroke. 2021 Jun;16(4):411-419. doi: 10.1177/1747493020950903. Epub 2020 Sep 2.
8
Aspirin adherence in subjects with glucose-6-phosphate-dehydrogenase deficiency having an acute coronary syndrome.葡萄糖-6-磷酸脱氢酶缺乏的急性冠状动脉综合征患者的阿司匹林依从性
Eur Heart J Cardiovasc Pharmacother. 2021 May 23;7(3):e41-w44. doi: 10.1093/ehjcvp/pvaa060.
9
Glucose-6-phosphate dehydrogenase deficiency.葡萄糖-6-磷酸脱氢酶缺乏症
Lancet. 2008 Jan 5;371(9606):64-74. doi: 10.1016/S0140-6736(08)60073-2.
10
Long-term, low-dose aspirin is safe in glucose-6-phosphate dehydrogenase deficiency.长期低剂量阿司匹林对于葡萄糖-6-磷酸脱氢酶缺乏症患者是安全的。
DICP. 1991 Oct;25(10):1074-5. doi: 10.1177/106002809102501010.

Aspirin in patients with glucose-6-phosphate dehydrogenase deficiency: a true clinical issue?

作者信息

Sarto Gianmarco, Soraci Emanuele, Sciarretta Sebastiano, Galli Mattia

机构信息

Department of Medical Surgical Sciences and Biotechnologies, Sapienza University of Rome, Corso della Repubblica 79, 04100 Latina, Italy.

ASP 5-Ospedale di Patti, Messina, Italy.

出版信息

Eur Heart J Cardiovasc Pharmacother. 2025 Mar 13;11(2):112-113. doi: 10.1093/ehjcvp/pvae101.

DOI:10.1093/ehjcvp/pvae101
PMID:39741392
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11905740/
Abstract
摘要